UTAMAMALAYSIADUNIAPOLITIKVIDEOHIBURANSUKANGAYA HIDUPBISNESENGLISHPODCASTFOTORANCANGANTEKNOLOGI

Remdesivir

Dapatkan berita terkini mengenai remdesivir dari Astro Awani

UK researchers cure man who had COVID for 411 days

UK researchers cure man who had COVID for 411 days

The man caught COVID in December 2020 and continued to test positive until January this year.
Sat Nov 05 2022
Thailand cadang beli ubat antiviral, kit ujian bernilai 4 billion baht

Thailand cadang beli ubat antiviral, kit ujian bernilai 4 billion baht

Ubat antiviral bernilai 3.995 bilion baht merangkumi 165 juta tablet Favipiravir dan Molnupiravir dan 57,000 vial Remdesivir serta 1 juta kit ujian pantas.
Mon Jul 18 2022
MOH grants conditional approval of Veklury for COVID-19 treatment

MOH grants conditional approval of Veklury for COVID-19 treatment

The MOH has granted conditional registration approval for Veklury (remdesivir) for the emergency treatment of COVID-19.
Thu Jul 07 2022
COVID-19: WHO jalankan kajian terhadap tiga lagi ubat rawat pesakit

COVID-19: WHO jalankan kajian terhadap tiga lagi ubat rawat pesakit

Tiga ubat-ubatan itu akan dimasukkan ke dalam kajian global yang sedang dijalankan bagi mengenal pasti potensi rawatan virus tersebut.
Thu Aug 12 2021
Breakthrough infections threaten NRP indicators and the fully-vaxxed

Breakthrough infections threaten NRP indicators and the fully-vaxxed

Breakthrough cases and high infectivity rate of variants could make vaccination targets to be underestimated.
Wed Aug 11 2021
COVID-19: Indonesia catat 1,025 korban, kes kematian harian tertinggi

COVID-19: Indonesia catat 1,025 korban, kes kematian harian tertinggi

Manakala 54,000 kes positif direkodkan dalam tempoh 24 jam.
Fri Jul 16 2021
COVID-19: Suruhanjaya Eropah cadang negara anggota bekerjasama hasilkan vaksin

COVID-19: Suruhanjaya Eropah cadang negara anggota bekerjasama hasilkan vaksin

Langkah itu akan membantu mewujudkan tambahan 10 rawatan berpotensi untuk virus COVID-19.
Thu May 06 2021
India bans Remdesivir exports as coronavirus rages on; rallies continue

India bans Remdesivir exports as coronavirus rages on; rallies continue

WHO in November issued a conditional recommendation against the use of Remdesivir in hospitalised patients.
Mon Apr 12 2021
WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patients

WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patients

There is no evidence it improves survival or reduces the need for ventilation.
Fri Nov 20 2020
Health DG: Avoid COVID-19 'cures' sold online

Health DG: Avoid COVID-19 'cures' sold online

The public is advised not to be deceived by medicines advertised on online shopping application that are purportedly effective in treating COVID-19 infection.
Fri Oct 23 2020
COVID-19: Remdesivir, hydroxychloroquine found not effective - Health DG

COVID-19: Remdesivir, hydroxychloroquine found not effective - Health DG

Anti-virus medicines such as remdesivir were found to be ineffective in treating COVID-19 patients as well as not helpful in reducing death cases of the outbreak.
Mon Oct 19 2020
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients

WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients

The regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among COVID-19 patients.
Fri Oct 16 2020
Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some

Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some

Results of the overall study suggested the drug may reduce mortality, but the benefit was not statistically significant.
Fri Oct 09 2020
Trump faces backlash for removing mask on return to White House

Trump faces backlash for removing mask on return to White House

Trump has repeatedly flouted social-distancing guidelines meant to curb the virus' spread and ignored his own medical advisers.
Tue Oct 06 2020
Experts raise questions about severity of Trump's COVID-19

Experts raise questions about severity of Trump's COVID-19

The biggest question would be is there a risk of deterioration, or is he on a good trajectory?
Mon Oct 05 2020